Can-Fite BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Cash & Equivalents	6.45	4.83	4.28	2.98	4.39	8.27	Upgrade
Short-Term Investments	0	3.06	4.64	5	14.51	-	Upgrade
Trading Asset Securities	-	-	-	0.01	0.24	0.08	Upgrade
Cash & Short-Term Investments	6.46	7.89	8.92	7.99	19.14	8.34	Upgrade
Cash Growth	36.55%	-11.60%	11.71%	-58.27%	129.40%	202.17%	Upgrade
Prepaid Expenses	1.17	1.02	0.91	1.12	0.88	1.04	Upgrade
Other Current Assets	-	0.08	0.08	0.05	0.05	0.02	Upgrade
Total Current Assets	7.62	8.98	9.91	9.16	20.07	9.4	Upgrade
Property, Plant & Equipment	0.1	0.14	0.08	0.13	0.19	0.12	Upgrade
Total Assets	7.72	9.12	9.99	9.28	20.25	9.52	Upgrade
Accounts Payable	1.15	0.62	0.43	0.9	0.95	0.56	Upgrade
Accrued Expenses	0.51	0.98	0.94	0.78	0.91	0.33	Upgrade
Current Portion of Leases	0.06	0.05	0.03	0.05	0.05	0.04	Upgrade
Current Unearned Revenue	0.41	0.41	0.62	0.78	0.82	0.33	Upgrade
Total Current Liabilities	2.12	2.05	2.02	2.5	2.73	1.27	Upgrade
Long-Term Leases	0.03	0.05	0.01	0.01	0.07	0.02	Upgrade
Long-Term Unearned Revenue	1.38	1.58	1.71	2.3	3.07	2.16	Upgrade
Total Liabilities	3.54	3.68	3.75	4.81	5.87	3.45	Upgrade
Common Stock	-	-	-	-	-	33.04	Upgrade
Additional Paid-In Capital	174.29	170.67	163.6	154.19	153.93	97.38	Upgrade
Retained Earnings	-171.24	-166.36	-158.48	-150.85	-140.67	-125.47	Upgrade
Comprehensive Income & Other	1.13	1.13	1.13	1.13	1.13	1.13	Upgrade
Total Common Equity	4.18	5.44	6.24	4.47	14.38	6.07	Upgrade
Shareholders' Equity	4.18	5.44	6.24	4.47	14.38	6.07	Upgrade
Total Liabilities & Equity	7.72	9.12	9.99	9.28	20.25	9.52	Upgrade
Total Debt	0.09	0.1	0.04	0.06	0.12	0.07	Upgrade
Net Cash (Debt)	6.37	7.78	8.88	7.93	19.02	8.28	Upgrade
Net Cash Growth	36.29%	-12.37%	12.08%	-58.32%	129.76%	208.12%	Upgrade
Net Cash Per Share	0.00	0.00	0.01	0.01	0.03	0.02	Upgrade
Filing Date Shares Outstanding	3,967	3,106	1,497	1,225	815.75	515.75	Upgrade
Total Common Shares Outstanding	3,967	2,983	1,360	815.75	815.75	463.77	Upgrade
Working Capital	5.5	6.93	7.89	6.66	17.34	8.13	Upgrade
Book Value Per Share	0.00	0.00	0.00	0.01	0.02	0.01	Upgrade
Tangible Book Value	4.18	5.44	6.24	4.47	14.38	6.07	Upgrade
Tangible Book Value Per Share	0.00	0.00	0.00	0.01	0.02	0.01	Upgrade
Machinery	-	0.08	0.28	0.28	0.27	0.26	Upgrade
Leasehold Improvements	-	-	0.01	0.01	0.01	0.01	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.